- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.10. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 16.10. | EQS-News: Instinct Bio Technical Company Holdings Inc.: Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal 2026 | 417 | EQS Group (EN) | EQS-News: Instinct Bio Technical Company Holdings Inc.
/ Key word(s): Financial
Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal... ► Artikel lesen | |
| 01.10. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.09. | EQS-News: Instinct Bio Technical Company Holdings Inc.: BIOT Named Authorized Representative for IN01 Cancer Immunotherapy in Japan and China | 466 | EQS Group (EN) | EQS-News: Instinct Bio Technical Company Holdings Inc.
/ Key word(s): Financial
BIOT Named Authorized Representative for IN01 Cancer Immunotherapy in Japan and China 30.09.2026... ► Artikel lesen | |
| 15.09. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 15.09. | EQS-News: INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.: Instinct Bio Receives Nasdaq Notifications Regarding Minimum Bid Requirement and Minimum Market Value of Listed Securities and Publicly Held Shares | 388 | EQS Group (EN) | EQS-News: INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.
/ Key word(s): Financial
Instinct Bio Receives Nasdaq Notifications Regarding Minimum Bid Requirement and Minimum Market... ► Artikel lesen | |
| 08.09. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.09. | Instinct Bio sichert Standort für Klinik in Jakarta und legt Abo-Preise fest | 1 | Investing.com Deutsch | ||
| INSTINCT BIO TECHNICAL Aktie jetzt für 0€ handeln | |||||
| 04.09. | Instinct Bio secures Jakarta clinic site, sets subscription tiers | 1 | Investing.com | ||
| 04.09. | Instinct Bio Technical Company Holdings Inc.: INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives | 307 | GlobeNewswire (Europe) | NEW YORK and TOKYO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (Nasdaq: BIOT) ("Instinct Bio" or the "Company") today provided an operational update on the initiatives... ► Artikel lesen | |
| 10.08. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 30.07. | EQS-News: INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.: Instinct Bio Announces Strategic Collaboration With INVITRX to Expand GENREVER Into U.S. and Advance Indonesia Regenerative Medicine Initiatives | 616 | EQS Group (EN) | EQS-News: INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.
/ Key word(s): Healthcare
Instinct Bio Announces Strategic Collaboration With INVITRX to Expand GENREVER... ► Artikel lesen | |
| 29.07. | Instinct Bio expandiert mit Abo-Modell für Schönheitskliniken nach Indonesien | 3 | Investing.com Deutsch | ||
| 29.07. | INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC.: BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand "GENRÊVER CLINIC" | 609 | GlobeNewswire (Europe) | NEW YORK and TOKYO, July 29, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. (NASDAQ: BIOT) ("Instinct Bio" or the "Company") today announced its decision to bring its own Japanese... ► Artikel lesen | |
| 29.07. | Instinct Bio Stock Slides After Hours: Here's What is Going on With BIOT | 9 | Benzinga.com | ||
| 28.07. | Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth | 368 | GlobeNewswire (Europe) | New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC: (Nasdaq: BIOT) ("Instinct Bio" or the "Company") today announced that it has entered into an indicative... ► Artikel lesen | |
| 28.07. | INSTINCT BIO TECHNICAL CO HOLDINGS INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 23.07. | Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its Nasdaq Debut Under the Ticker "BIOT" on July 24, 2026 | 509 | GlobeNewswire (Europe) | New York, NY, Las Vegas, NV, Tokyo, JP, July 23, 2026 (GLOBE NEWSWIRE) -- INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC. ("Instinct Bio," "BIOT," or the "Company"), the parent company of Instinct Bio... ► Artikel lesen | |
| 13.11.25 | Relativity Acquisition Corp. SPAC and Instinct Bio Technical Co. Announce Effectiveness of Registration Statement | 230 | GlobeNewswire (Europe) | Las Vegas, NV, Tokyo, Japan, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Special purpose acquisition company, Relativity Acquisition Corp. ("Relativity"), and Instinct Bio Technical Company Inc. ("Instinct... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 60,86 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 55,44 | +0,01 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| LIFESTANCE HEALTH GROUP | 12,565 | +0,04 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| FRESENIUS | 45,405 | +0,22 % | ROUNDUP: Fresenius besetzt Kabi-Führung neu - Verlängerung für Finanzchefin | BAD HOMBURG (dpa-AFX) - Der Gesundheitskonzern Fresenius besetzt die Führung seiner Pharma- und Medizintechniktochter Kabi neu. Der bisherige Leiter der Geschäftsbereiche Pharma und Nutrition, Marc-Alexander... ► Artikel lesen | |
| CONCENTRA GROUP | 39,970 | 0,00 % | Stephens initiates Concentra stock with overweight on health model | ||
| PROGYNY | 29,120 | 0,00 % | Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report | ||
| AVEANNA HEALTHCARE | 13,310 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,010 | -0,10 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 28,310 | 0,00 % | Kestra Medical Technologies: Evercore-Einstufung treibt Aktie vorbörslich an | ||
| ALIGNMENT HEALTHCARE | 8,430 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors | ||
| SIEMENS HEALTHINEERS | 41,780 | +0,05 % | ANALYSE-FLASH: RBC hebt Ziel für Siemens Healthineers auf 48 Euro - 'Outperform' | NEW YORK (dpa-AFX Broker) - Die kanadische Bank RBC hat das Kursziel für Siemens Healthineers von 45 auf 48 Euro angehoben und die Einstufung auf "Outperform" belassen. Der Start des neuen Strahlentherapiesystems... ► Artikel lesen | |
| GENEDX | 67,26 | 0,00 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| FRESENIUS MEDICAL CARE | 39,780 | +1,53 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BILLIONTOONE | 105,67 | -0,01 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,890 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |
INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,202 Euro und damit -1,47 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INSTINCT BIO TECHNICAL COMPANY HOLDINGS INC finden Sie auf Wallstreet Online.